VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 187 filers reported holding VAXCYTE INC in Q1 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,059,570 | +2.1% | 275,786 | 0.0% | 0.03% | +7.1% |
| Q2 2023 | $13,772,753 | +47.6% | 275,786 | +10.8% | 0.03% | +40.0% |
| Q1 2023 | $9,328,247 | -21.7% | 248,886 | +0.1% | 0.02% | -25.9% |
| Q4 2022 | $11,917,301 | +379.4% | 248,536 | +140.0% | 0.03% | +350.0% |
| Q3 2022 | $2,486,000 | +52.5% | 103,575 | +38.3% | 0.01% | +50.0% |
| Q2 2022 | $1,630,000 | +88.0% | 74,910 | +108.7% | 0.00% | +100.0% |
| Q1 2022 | $867,000 | +2450.0% | 35,900 | +2428.2% | 0.00% | – |
| Q4 2021 | $34,000 | -91.7% | 1,420 | -93.2% | 0.00% | -100.0% |
| Q1 2021 | $412,000 | -25.8% | 20,873 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $555,000 | – | 20,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $90,711,000 | 29.04% |
| Medicxi Ventures Management (Jersey) Ltd | 3,774,956 | $82,142,000 | 17.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 832,166 | $18,108,000 | 9.12% |
| GREAT POINT PARTNERS LLC | 985,153 | $21,437,000 | 5.14% |
| Kynam Capital Management, LP | 723,781 | $15,749,000 | 4.02% |
| Ghost Tree Capital, LLC | 325,000 | $7,072,000 | 3.68% |
| Frazier Life Sciences Management, L.P. | 1,787,405 | $38,894,000 | 3.67% |
| RA Capital Management | 4,581,203 | $99,687,000 | 2.66% |
| Opaleye Management Inc. | 190,000 | $4,134,000 | 1.86% |
| Soleus Capital Management, L.P. | 370,650 | $8,065,000 | 1.26% |